Is Aprotinin Safe to Use in a Cohort at Increased Risk for Thrombotic Events: Results From a Randomized, Prospective Trial in Off-Pump Coronary Artery Bypass

Annals of Thoracic Surgery

Volumn 86, Issue 3, 2008, Pages 815-822

  Grant, Michael C ^a   Kon, Zachary ^a   Joshi, Ashish ^b   Christenson, Eric ^a   Kallam, Seeta ^a   Burris, Nicholas ^a   Gu, Junyan ^a   Poston, Robert S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Marylandw Baltimore County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; SODIUM CHLORIDE;

AREA UNDER THE CURVE; ARTICLE; BLEEDING; CALCULATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HUMAN; KIDNEY INJURY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; THROMBOSIS;

APROTININ; BLOOD COAGULATION TESTS; CORONARY ARTERY BYPASS, OFF-PUMP; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOSTATICS; HUMANS; PLATELET FUNCTION TESTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; THROMBOSIS;

EID: 49549087337     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.04.047     Document Type: Article

References (28)

1. Mangano D.T., Tudor I.C., Dietzel C., and Multicenter Study of Perioperative Ischemia Research Group. Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
2. Monroe D.M., Hoffman M., and Roberts H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22 (2002) 1381-1389
3. Kon Z.N., Kwon M.H., Collins M.J., et al. Off-pump coronary artery bypass leads to a regional hypercoagulable state not detectable using systemic markers. Innovations Tech Cardiac Surg 1 (2006) 232-238
4. Lim E., Drain A., Davies W., Edmonds L., and Rosengard B.R. A systematic review of randomized trials comparing revascularization rate and graft patency of off-pump and conventional coronary surgery. J Thorac Cardiovasc Surg 132 (2006) 1409-1413
5. Takagi H., Tanabashi T., Kawai N., Kato T., and Umemoto T. Off-pump coronary artery bypass sacrifices graft patency: meta-analysis of randomized trials. J Thorac Cardiovasc Surg 133 (2007) e2-e3
6. Brown J.M., Poston R.S., Gammie J.S., et al. Off-pump versus on-pump coronary artery bypass grafting in consecutive patients: decision-making algorithm and outcomes. Ann Thorac Surg 81 (2006) 555-561
7. Beath S.M., Nuttall G.A., Fass D.N., Oliver Jr. W.C., Ereth M.H., and Oyen L.J. Plasma aprotinin concentrations during cardiac surgery: full-versus half-dose regimens. Anesth Analg 91 (2000) 257-264
8. Levey A.S., Greene T., Kusek J., and Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A
9. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P., and Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8 (2004) R204-R212
10. Wali R.K., Mohanlal V., Ramos E., et al. Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction. Am J Transplant 7 (2007) 1572-1583
11. Mehta R.H., Grab J.D., O'Brien S.M., et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 114 (2006) 2208-2216
12. Fergusson D., Aaron S.D., Guyatt G., and Hébert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 325 (2002) 652-654
13. Páramo J.A., Orbe J., and Fernández J. Fibrinolysis/proteolysis balance in stable angina pectoris in relation to angiographic findings. Thromb Haemost 86 (2006) 636-639
14. Nordenhem A., Leander K., Hallqvist J., de Faire U., Sten-Linder M., and Wiman B. The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project. Thromb Res 116 (2005) 223-232
15. Mangano D.T., Miao Y., Vuylsteke A., et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297 (2007) 471-479
16. Mark Levenson, Ph.D. Post-market safety of aprotinin (Trasylol). Statistical review of the observational studies of aprotinin safety part I: Methods, Mangano and Karkouti Studies. CRDAC and DSaRM Meeting. September 12, 2007. Available at: http://www.fda.gov/OHRMS/DOCKETS/AC/07/slides/2007-4316s1-12-FDA-Levenson_files/frame.htm. Accessed October 3, 2007.
17. Brown J.R., Birkmeyer N.J., and O'Connor G.T. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115 (2007) 2801-2813
18. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
19. Rustom R., Grime J.S., Maltby P., Stockdale H.R., Critchley M., and Bone J.M. Observations on the early renal uptake and later tubular metabolism of radiolabelled aprotinin (Trasylol) in man: theoretical and practical considerations. Clin Sci (Lond) 84 (1993) 231-235
20. Dietrich W., Busley R., and Kriner M. High-dose aprotinin in cardiac surgery: is high-dose high enough?. An analysis of 8281 cardiac surgical patients treated with aprotinin. Anesth Analg 103 (2006) 1074-1081
21. Hoste E.A., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 10 (2006) R73 Epub 2006 May 12
22. Nuttall G.A., Fass D.N., Oyen L.J., Oliver Jr. W.C., and Ereth M.H. A study of a weight-adjusted aprotinin dosing schedule during cardiac surgery. Anesth Analg 94 (2002) 283-289
23. Alderman E.L., Levy J.H., Rich J.B., et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 116 (1998) 716-730
24. Ogawa M., Yaku H., Doi K., et al. Does off-pump coronary artery bypass grafting beneficially affect renal function?. ANZ J Surg 75 (2005) 675-679
25. Sellke F.W., DiMaio J.M., Caplan L.R., et al. Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation 111 (2005) 2858-2864
26. Royston D. Aprotinin prevents bleeding and has effects on platelets and fibrinolysis. J Cardiothorac Vasc Anesth 5 6 suppl 1 (1991) 18-23
27. Puskas J.D., Williams W.H., Duke P.G., et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 797-808
28. Day J.R., Landis R.C., and Taylor K.M. Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction. Semin Cardiothorac Vasc Anesth 10 (2006) 132-142